Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 6/2010

01-06-2010 | Original Article

Kinesitherapy alleviates fatigue in terminal hospice cancer patients—an experimental, controlled study

Authors: Tomasz Buss, Krystyna de Walden-Gałuszko, Aleksandra Modlińska, Magdalena Osowicka, Monika Lichodziejewska-Niemierko, Justyna Janiszewska

Published in: Supportive Care in Cancer | Issue 6/2010

Login to get access

Abstract

Purpose

The study was focused on the influence of the kinesitherapy on fatigue and the quality of life in the terminal hospice cancer patients.

Patients and methods

Forty-nine patients were included into the study and divided into experimental group A (with kinesitherapy) with 30 subjects and control group B (without kinesitherapy) with 19 subjects. Patients from group A did the exercises three times a week, for 20–30 min, for the period of 3–4 weeks. The exercises were individually supervised by a physiotherapist, following a carefully worked out pattern. In both groups, the changes in the intensity of fatigue and the quality of life were observed by means of using Rotterdam symptom checklist, brief fatigue inventory, and visual analogue fatigue scale.

Results

In group A, the intensity of fatigue decreased significantly after 3 weeks of kinesitherapy. In group B, fatigue deteriorated significantly in comparison with the initial measurement. The intensity of physical symptoms in group A decreased significantly after 2 weeks of kinesitherapy, whereas in group B, increased after 2 weeks of observation. The quality of life in group A remained stable throughout the study. A tendency towards the deterioration of the quality of life with the time passing in group B was noticeable.

Conclusion

Our analysis showed that, on average, after 3 weeks of kinesitherapy, a significant decrease of the intensity of fatigue was observed, while in the control group, it increased after 2 weeks of observation. The obtained results provide evidence that a planned set of exercises decreases cancer-related fatigue effectively.
Literature
1.
Higginson IJ, Costantini M (2008) Dying with cancer, living well with advanced cancer. Eur J Cancer 44(10):1414–1424CrossRefPubMed
2.
3.
Solano JP, Gomes B, Higginson IJ (2006) A comparison of symptom prevalence in far advanced cancer, AIDS, heart disease, chronic obstructive pulmonary disease and renal disease. J Pain Symptom Manage 31(1):58–69CrossRefPubMed
4.
Doorenbos AZ et al (2006) Symptom experience in the last year of life among individuals with cancer. J Pain Symptom Manage 32(5):403–412CrossRefPubMed
5.
Lundh Hagelin C, Seiger A, Furst CJ (2006) Quality of life in terminal care—with special reference to age, gender and marital status. Support Care Cancer 14(4):320–328CrossRefPubMed
6.
Tsai JS et al (2006) Symptom patterns of advanced cancer patients in a palliative care unit. Palliat Med 20(6):617–622CrossRefPubMed
7.
Buss T (2006) The clinical and therapeutic aspects of fatigue in hospice cancer patients. Doctoral thesis. Department of Palliative Medicine, Medical University of Gdańsk, Gdańsk
8.
Loge JH et al (1999) Hodgkin’s disease survivors more fatigued than the general population. J Clin Oncol 17(1):253–261PubMed
9.
Walsh D, Donnelly S, Rybicki L (2000) The symptoms of advanced cancer: relationship to age, gender, and performance status in 1000 patients. Support Care Cancer 8(3):175–179CrossRefPubMed
10.
Hofman M et al (2007) Cancer-related fatigue: the scale of the problem. Oncologist 12(Suppl 1):4–10CrossRefPubMed
11.
Echteld MA et al (2007) Multidimensional fatigue and its correlates in hospitalised advanced cancer patients. Eur J Cancer 43(6):1030–1036CrossRefPubMed
12.
Cella D et al (2002) Fatigue in cancer patients compared with fatigue in the general United States population. Cancer 94(2):528–538CrossRefPubMed
13.
Cohen SR, Leis A (2002) What determines the quality of life of terminally ill cancer patients from their own perspective? J Palliat Care 18(1):48–58PubMed
14.
Vogelzang NJ et al (1997) Patient, caregiver, and oncologist perceptions of cancer-related fatigue: results of a tripart assessment survey. The fatigue coalition. Semin Hematol 34(3 Suppl 2):4–12PubMed
15.
Curt GA et al (2000) Impact of cancer-related fatigue on the lives of patients: new findings from the Fatigue Coalition. Oncologist 5(5):353–360CrossRefPubMed
16.
Ferreira KA et al (2008) Impact of cancer-related symptom synergisms on health-related quality of life and performance status. J Pain Symptom Manage 35(6):604–616CrossRefPubMed
17.
Brown DJ, McMillan DC, Milroy R (2005) The correlation between fatigue, physical function, the systemic inflammatory response, and psychological distress in patients with advanced lung cancer. Cancer 103(2):377–382CrossRefPubMed
18.
Mock V et al (1997) Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum 24(6):991–1000PubMed
19.
Mock V et al (2001) Fatigue and quality of life outcomes of exercise during cancer treatment. Cancer Pract 9(3):119–127CrossRefPubMed
20.
Segal RJ et al (2003) Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol 21(9):1653–1659CrossRefPubMed
21.
Segal R et al (2001) Structured exercise improves physical functioning in women with stages I and II breast cancer: results of a randomized controlled trial. J Clin Oncol 19(3):657–665PubMed
22.
Dimeo F, Rumberger BG, Keul J (1998) Aerobic exercise as therapy for cancer fatigue. Med Sci Sports Exerc 30(4):475–478PubMed
23.
Mock V, Abernethy AP, Atkinson A et al (2006) NCCN practice guidelines in oncology—v.1.2006. Cancer-related fatigue
24.
Yoshioka H (1994) Rehabilitation for the terminal cancer patient. Am J Phys Med Rehabil 73(3):199–206CrossRefPubMed
25.
Porock D et al (2000) An exercise intervention for advanced cancer patients experiencing fatigue: a pilot study. J Palliat Care 16(3):30–36PubMed
26.
Oldervoll LM et al (2006) The effect of a physical exercise program in palliative care: a phase II study. J Pain Symptom Manage 31(5):421–430CrossRefPubMed
27.
Adamsen L et al (2005) The effect of a multidimensional exercise intervention on physical capacity, well-being and quality of life in cancer patients undergoing chemotherapy. Support Care Cancer 14(2):116–127CrossRefPubMed
28.
Niemkiewicz DKL (2001) The methods of functional improvement of the critically ill patients. In: Szulc R (ed) The functional improvement of the critically ill patients. Wydawnictwo Medyczne Urban and Partner, Wrocław, pp 127–140
29.
de Haes JC, van Knippenberg FC, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer 62(6):1034–1038PubMed
30.
Mendoza TR et al (1999) The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer 85(5):1186–1196CrossRefPubMed
31.
Newell S et al (1998) How well do medical oncologists’ perceptions reflect their patients’ reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer 83(8):1640–1651CrossRefPubMed
32.
Radbruch L et al (2008) Fatigue in palliative care patients—an EAPC approach. Palliat Med 22(1):13–32CrossRefPubMed
Metadata
Title
Kinesitherapy alleviates fatigue in terminal hospice cancer patients—an experimental, controlled study
Authors
Tomasz Buss
Krystyna de Walden-Gałuszko
Aleksandra Modlińska
Magdalena Osowicka
Monika Lichodziejewska-Niemierko
Justyna Janiszewska
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-009-0709-0

Other articles of this Issue 6/2010

Supportive Care in Cancer 6/2010 Go to the issue

Original Article

Evaluation of analgesic effect and safety of fentanyl transdermal patch for cancer pain as the first line

Original Article

Prospective survey of sexual function among patients with clinically localized prostate cancer referred for definitive radiotherapy and the impact of radiotherapy on sexual function

Original Article

Is bra discomfort a barrier to exercise for breast cancer patients?

Original Article

Zoledronic acid concurrent with either high- or reduced-dose palliative radiotherapy in the management of the breast cancer patients with bone metastases: a phase IV randomized clinical study

Review Article

Sexual issues in early and late stage cancer: a review

Original Article

Gustatory and olfactory function in breast cancer patients
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits